Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 24-Mar-23 12:35 PM View:  | Metacrine, Inc. (MTCR) | 23-Mar-23 | Grant | 842,211 | $0.47 | $395,839.00 | (38%) 2.23M to 1.38M | (15%) |
| 27-Jan-23 4:42 PM View: | Metacrine, Inc. (MTCR) | 26-Jan-23 | Sale | 380,605 | $0.41 | $157,266.00 | (41%) 922.51K to 541.9K | |
| 20-Apr-22 4:25 PM View: | Metacrine, Inc. (MTCR) | 19-Apr-22 | Market Sale | 44,748 | $0.50 | $22,472.10 | (5%) 967.26K to 922.51K | (8%) |
| 18-Apr-22 5:28 PM View: | Metacrine, Inc. (MTCR) | 14-Apr-22 | Grant | 104,500 | -- | -- | 12% 862.76K to 967.26K | |
| 01-Mar-22 4:56 PM View: | Metacrine, Inc. (MTCR) | 27-Feb-22 | Grant | 842,211 | -- | -- | 4099% 20.55K to 862.76K | |
| 20-May-21 6:55 PM View: | Metacrine, Inc. (MTCR) | 20-May-21 | Market Purchase | 20,547 | $3.64 | $74,692.50 | 100% 0 to 20.55K | 2% |
| 16-Oct-19 8:20 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 14-Oct-19 | Payment of Exercise | 2,309 | $47.32 | $109,262.00 | (37%) 6.3K to 3.99K | (59%) |
| 16-Oct-19 8:20 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 14-Oct-19 | Option Exercise | 6,300 | -- | -- | 100% 0 to 6.3K | |
| 08-Jan-19 9:04 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 08-Jan-19 | Option Exercise | 3,000 | $15.10 | $45,300.00 | 100% 0 to 3.0K | |
| 08-Jan-19 9:04 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 08-Jan-19 | Market Option Sale (Planned) | 3,000 | $44.00 | $132,000.00 | (100%) 3.0K to 0 | (72%) |
| 08-Jan-19 9:04 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 07-Jan-19 | Option Exercise | 16,000 | $15.10 | $241,600.00 | 100% 0 to 16.0K | |
| 08-Jan-19 9:04 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 07-Jan-19 | Market Option Sale (Planned) | 16,000 | $41.69 | $667,066.00 | (100%) 16.0K to 0 | (81%) |
| 04-Feb-16 12:06 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 30-Nov-15 | Grant | 4,170 | $2.03 | $8,465.10 | 70% 5.99K to 10.16K | |
| 04-Feb-16 12:06 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 30-May-15 | Grant | 1,860 | $4.17 | $7,756.20 | 45% 4.13K to 5.99K | |
| 05-Feb-15 5:32 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 28-Nov-14 | Grant | 1,542 | $4.92 | $7,586.64 | 60% 2.59K to 4.13K | |
| 05-Feb-15 5:32 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 30-May-14 | Grant | 1,318 | $5.25 | $6,919.50 | 104% 1.27K to 2.59K | |
| 11-Feb-14 7:33 AM View: | Orexigen Therapeutics, Inc. (OREXQ) | 29-Nov-13 | Grant | 1,270 | $5.34 | $6,781.80 | 100% 0 to 1.27K | |
| 29-Jul-13 7:49 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 25-Jul-13 | Option Exercise | 71,229 | $1.66 | $118,240.00 | 100% 0 to 71.23K | |
| 29-Jul-13 7:49 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 25-Jul-13 | Market Option Sale (Planned) | 71,229 | $7.16 | $510,000.00 | (100%) 71.23K to 0 | 96% |
| 30-May-13 5:38 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 28-May-13 | Option Exercise | 28,771 | $1.66 | $47,759.90 | 100% 0 to 28.77K | |
| 30-May-13 5:38 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 28-May-13 | Market Option Sale (Planned) | 28,771 | $7.21 | $207,358.00 | (100%) 28.77K to 0 | 96% |